Special Issue "Emerging Trends in Lipoprotein and Cardiovascular Diseases"
Deadline for manuscript submissions: 31 March 2024 | Viewed by 4415
Interests: health promotion for cardiometabolic diseases
High-density lipoproteins (HDL) have a unique lipid metabolism status, and have important clinical implications as biomarkers. It is well known that low HDL cholesterol is a risk factor for atherosclerotic cardiovascular disease; however, many clinical concerns require further investigation. HDL cholesterol interacts, directly or indirectly, with various substances in the blood, as well as with other lipids. Furthermore, HDL cholesterol has several subclasses, and additional research is required to better understand how they work differently to cardiometabolic health issues. Furthermore, detailing implications according to gender, ethnicity, age group, and interrelationships with drugs and nutrition will also be critical biomedical aspects to consider in clinical settings. Beyond the conventional understanding of HDL cholesterol, it is time for advanced research pertaining to technological advances in various clinical contexts. We encourage worldwide participation from researchers interested in cardiovascular and metabolic health.
Prof. Dr. Yong-Jae Lee
Dr. Byoungjin Park
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- high-density lipoproteins
- cardiovascular disease
- molecular interactions in cardiometabolic health
- cardiovascular risk prediction